Marco Dauriz

2.6k total citations
46 papers, 1.6k citations indexed

About

Marco Dauriz is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Marco Dauriz has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Epidemiology. Recurrent topics in Marco Dauriz's work include Diabetes Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Marco Dauriz is often cited by papers focused on Diabetes Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Marco Dauriz collaborates with scholars based in Italy, United Kingdom and Australia. Marco Dauriz's co-authors include Giovanni Targher, Enzo Bonora, Giacomo Zoppini, Alessandro Mantovani, Christopher D. Byrne, Stefano Bonapace, James B. Meigs, Isabella Pichiri, Lorenza Santi and Salvatore Badalamenti and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Marco Dauriz

46 papers receiving 1.6k citations

Peers

Marco Dauriz
You‐Bin Lee South Korea
Jiin Ahn South Korea
Ki‐Chul Sung South Korea
Kap Bum Huh South Korea
Ji Cheol Bae South Korea
Scott Isaacs United States
You‐Bin Lee South Korea
Marco Dauriz
Citations per year, relative to Marco Dauriz Marco Dauriz (= 1×) peers You‐Bin Lee

Countries citing papers authored by Marco Dauriz

Since Specialization
Citations

This map shows the geographic impact of Marco Dauriz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Dauriz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Dauriz more than expected).

Fields of papers citing papers by Marco Dauriz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Dauriz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Dauriz. The network helps show where Marco Dauriz may publish in the future.

Co-authorship network of co-authors of Marco Dauriz

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Dauriz. A scholar is included among the top collaborators of Marco Dauriz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Dauriz. Marco Dauriz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moghetti, Paolo, Cecilia Catellani, Chiara Sartori, et al.. (2023). Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS. Journal of Endocrinological Investigation. 46(12). 2629–2637. 1 indexed citations
2.
Bonora, Enzo, Maddalena Trombetta, Marco Dauriz, et al.. (2020). Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9. BMJ Open Diabetes Research & Care. 8(1). e001549–e001549. 55 indexed citations
3.
Street, Maria Elisabeth, Francesca Cirillo, Cecilia Catellani, et al.. (2020). Current treatment for polycystic ovary syndrome: focus on adolescence. PubMed. 72(4). 288–311. 11 indexed citations
4.
Strollo, Rocky, Ernesto Maddaloni, Marco Dauriz, et al.. (2020). Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths. Diabetes Research and Clinical Practice. 171. 108444–108444. 23 indexed citations
5.
Zoppini, Giacomo, Corinna Bergamini, Maddalena Trombetta, et al.. (2019). Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls. Journal of Endocrinological Investigation. 42(9). 1109–1115. 4 indexed citations
6.
Zusi, Chiara, Alessandro Mantovani, Francesca Olivieri, et al.. (2019). Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. Digestive and Liver Disease. 51(11). 1586–1592. 35 indexed citations
7.
Calvo, Vincenzo, et al.. (2019). Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning. Acta Diabetologica. 57(1). 23–30. 8 indexed citations
8.
Dauriz, Marco, Nuccia Morici, Lucio Gonzini, et al.. (2019). Fifteen-Year Trends of Cardiogenic Shock and Mortality in Patients with Diabetes and Acute Coronary Syndromes. The American Journal of Medicine. 133(3). 331–339.e2. 10 indexed citations
9.
Sesti, Giorgio, Angelo Avogaro, Sara Belcastro, et al.. (2019). Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus. Acta Diabetologica. 56(6). 605–617. 54 indexed citations
10.
Zoppini, Giacomo, Corinna Bergamini, Alessandro Mantovani, et al.. (2018). The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies. PLoS ONE. 13(12). e0209794–e0209794. 10 indexed citations
11.
Zoppini, Giacomo, Ugo Fedeli, Elena Schievano, et al.. (2018). Mortality from infectious diseases in diabetes. Nutrition Metabolism and Cardiovascular Diseases. 28(5). 444–450. 52 indexed citations
12.
Ferraro, Pietro Manuel, et al.. (2018). Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. Metabolism. 83. 225–233. 91 indexed citations
13.
Marchetti, Luca, et al.. (2018). A closed-loop multi-level model of glucose homeostasis. PLoS ONE. 13(2). e0190627–e0190627. 12 indexed citations
14.
Dauriz, Marco, Alessandro Mantovani, Stefano Bonapace, et al.. (2017). Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis. Diabetes Care. 40(11). 1597–1605. 76 indexed citations
15.
Dauriz, Marco, Lorenza Santi, Carlo Negri, et al.. (2017). Psychological distress, self-efficacy and glycemic control in type 2 diabetes. Nutrition Metabolism and Cardiovascular Diseases. 27(4). 300–306. 52 indexed citations
16.
Santi, Francesca De, Giacomo Zoppini, Francesca Locatelli, et al.. (2017). Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population. BMC Pulmonary Medicine. 17(1). 101–101. 37 indexed citations
17.
Trombetta, Maddalena, Marco Dauriz, D. Travia, et al.. (2016). Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5. Nutrition Metabolism and Cardiovascular Diseases. 26(3). 232–238. 5 indexed citations
18.
Targher, Giovanni, Marco Dauriz, Cécile Laroche, et al.. (2016). In-Hospital and 1-Year Mortality Associated with Diabetes in Patients with Acute Heart Failure: Results from the ESC-HFA Heart Failure Long-Term Registry. European Journal of Heart Failure. 19(1). 54–65. 121 indexed citations
19.
Mantovani, Alessandro, Matteo Pernigo, Corinna Bergamini, et al.. (2015). Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Metabolism. 64(8). 879–887. 82 indexed citations
20.
Dauriz, Marco & James B. Meigs. (2014). Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease. Current Cardiovascular Risk Reports. 8(1). 368–368. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026